532 related articles for article (PubMed ID: 26859493)
1. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
[TBL] [Abstract][Full Text] [Related]
2. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
3. The cystic fibrosis lung microbiome.
Surette MG
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
[TBL] [Abstract][Full Text] [Related]
4. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
[TBL] [Abstract][Full Text] [Related]
5. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
[TBL] [Abstract][Full Text] [Related]
6. The metabolic footprint of the airway bacterial community in cystic fibrosis.
Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
[TBL] [Abstract][Full Text] [Related]
7. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
[No Abstract] [Full Text] [Related]
8. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.
Flight WG; Smith A; Paisey C; Marchesi JR; Bull MJ; Norville PJ; Mutton KJ; Webb AK; Bright-Thomas RJ; Jones AM; Mahenthiralingam E
J Clin Microbiol; 2015 Jul; 53(7):2022-9. PubMed ID: 25878338
[TBL] [Abstract][Full Text] [Related]
9. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
[TBL] [Abstract][Full Text] [Related]
10. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
[TBL] [Abstract][Full Text] [Related]
11. Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients.
Bosch A; Miñán A; Vescina C; Degrossi J; Gatti B; Montanaro P; Messina M; Franco M; Vay C; Schmitt J; Naumann D; Yantorno O
J Clin Microbiol; 2008 Aug; 46(8):2535-46. PubMed ID: 18550747
[TBL] [Abstract][Full Text] [Related]
12. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
Kolak M; Karpati F; Monstein HJ; Jonasson J
Int J Med Microbiol; 2003 Aug; 293(4):309-17. PubMed ID: 14503795
[TBL] [Abstract][Full Text] [Related]
13. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
Parkins MD; Floto RA
J Cyst Fibros; 2015 May; 14(3):293-304. PubMed ID: 25881770
[TBL] [Abstract][Full Text] [Related]
14. Intragenomic and intraspecific heterogeneity of the 16S rRNA gene in seven bacterial species from the respiratory tract of cystic fibrosis patients assessed by PCR-Temporal Temperature Gel Electrophoresis.
Michon AL; Jumas-Bilak E; Imbert A; Aleyrangues L; Counil F; Chiron R; Marchandin H
Pathol Biol (Paris); 2012 Jun; 60(3):e30-5. PubMed ID: 21621347
[TBL] [Abstract][Full Text] [Related]
15. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
16. The genus Prevotella in cystic fibrosis airways.
Field TR; Sibley CD; Parkins MD; Rabin HR; Surette MG
Anaerobe; 2010 Aug; 16(4):337-44. PubMed ID: 20412865
[TBL] [Abstract][Full Text] [Related]
17. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
18. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
[TBL] [Abstract][Full Text] [Related]
19. [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis].
Moissenet D; Bingen E; Arlet G; Vu-Thien H
Pathol Biol (Paris); 2005; 53(8-9):500-2. PubMed ID: 16081224
[TBL] [Abstract][Full Text] [Related]
20. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].
Menetrey Q; Dupont C; Chiron R; Marchandin H
Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
